Author

B Feagan

Institutions: Western University, London Health Sciences Centre, Alimentiv Inc. (Canada)

Observed institutions: Western University, London Health Sciences Centre, Alimentiv Inc. (Canada)

OpenAlex ID: A5027439028

A31 Mirikizumab Improves Quality of Life in Moderately-to-severely Active Uc: Improvement in Ibdq Scores in Participants of Lucent-1 and Lucent-2 Randomized, Double-blind, Placebo-controlled Phase 3 Trials

2023 · B E Sands, B Feagan, et al. · Journal of the Canadian Association of Gastroenterology · 1

A130 Evaluating Placebo Rates in Eosinophilic Esophagitis Randomized Controlled Trials: a Systematic Review and Meta-analysis

2025 · N S Ahmed, A Rivas, et al. · Journal of the Canadian Association of Gastroenterology

P0238 Reliability of magnetic resonance imaging indices for evaluating perianal fistulizing disease activity in paediatric Crohn’s disease

2025 · E Crowley, J Karpewycz, et al. · Journal of Crohn s and Colitis

Works count: 3

Citation count: 1

H-index: 1

I10-index: